Background: This study sought to determine the prevaccine type-specific prevalence of
human papillomavirus (HPV)–associated cancers in the United States to evaluate the …

Globally, human papillomavirus (HPV) infection is one of the most common sexually
transmitted infection. HPV is linked to at least five malignancies including vulvar, vaginal …

Human papillomavirus (HPV) is a necessary cause of cervical cancer. In addition, on the
basis of the fulfillment of a combination of viral as well as epidemiological criteria, it is …

Abstract Background: Previous Costa Rica Vaccine Trial (CVT) reports separately
demonstrated vaccine efficacy against HPV16 and HPV18 (HPV16/18) infections at the …

Background Cervical cancer is the greater cause of cancer death in women in many
developing countries. Persistent infection with human papilloma virus (HPV), primarily high …

Human papillomavirus (HPV) is the most common sexually transmitted infectious agent; its
14 oncogenic types are causally associated with 5–10% of all cancers. The major structural …

Currently, two prophylactic human papillomavirus (HPV) vaccines targeting HPV 16 and 18
have been shown to be highly efficacious for preventing precursor lesions although the …

The availability of a “cancer vaccine” has elicited enormous enthusiasm from the medical
community and the public, culminating in advocacy for mandatory vaccination against …

Human Papillomavirus (HPV) infection causes cervical cancer, a significant portion of anal,
vulvar, vaginal, and oropharyngeal cancers, genital warts, and recurrent respiratory …

Abstract Background The United States (US) Food & Drug Administration (FDA) recently
approved a human papillomavirus (HPV) vaccine with the purpose of reducing the risk of …